CARE-ONCBurnout Prevention Program for First-Year Medical Oncology Residents
This study aims to prevent burnout among first-year medical oncology residents by evaluating their emotional exhaustion, depersonalization, and personal accomplishment using the Maslach Burnout Inventory-Human Services Survey.
Self-Care and Burnout Prevention Program
Occupational Stress+4
+ Burnout, Psychological
+ Behavior
Prevention Study
Summary
Study start date: March 2, 2026
Actual date on which the first participant was enrolled.This study focuses on first-year medical oncology residents affiliated with FALP. The main goal is to understand and prevent burnout among these residents over a period of 12 months. The study uses a mix of methods, including a self-care and burnout prevention program. This research is important as it aims to help future medical oncology residents manage stress and prevent burnout, improving their overall well-being and the quality of care they provide. During the study, participants will engage in a burnout prevention program that lasts 12 months. Their participation and attendance will be tracked throughout the program. The program's effectiveness will be measured using the Maslach Burnout Inventory-Human Services Survey (MBI-HSS), which looks at emotional exhaustion, depersonalization, and personal accomplishment. At the end of the program, residents will share their satisfaction and perceived usefulness of the program. Feedback from participants and faculty will be used to identify any challenges and opportunities for improvement in future programs.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.9 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Prevention Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalStudy Objectives
Primary Objectives
Secondary Objectives